Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swire Group is a highly diversified global conglomerate with a significant and growing presence in the healthcare sector, primarily focused on Mainland China and Southeast Asia. Through its dedicated healthcare division, the company invests in and operates a portfolio of high-quality private hospitals, specialty clinics, and senior living facilities. Key investments include Columbia China, which operates multi-specialty hospitals and rehabilitation centers, and DeltaHealth, a provider specializing in cardiovascular care. Unlike traditional biotechnology firms, Swire Group functions as a strategic operator and investor, leveraging its long-term capital and operational expertise to scale healthcare services. The company aims to address the increasing demand for premium medical services driven by an aging population and a growing middle class in the Asia-Pacific region. Swire's healthcare strategy is integrated into its broader corporate structure, which also includes major interests in aviation, beverages, and property.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swire Group.